Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/11/2014 | CN102649765B Emodin di-n-octyl quaternary ammonium salt with anti-leukemia activity and preparation method thereof |
06/11/2014 | CN102641328B Malaytea scurfpea fruit extract, as well as preparation and application methods thereof |
06/11/2014 | CN102633852B Imine stigmasterol derivative and application thereof in anti-cancer drug |
06/11/2014 | CN102627578B Phenyl benzylamine compound and application thereof |
06/11/2014 | CN102614194B Externally applied medicine for treating skin disease and application thereof |
06/11/2014 | CN102614163B Intestinal targeted sustained-release amino acid medicine and preparation method thereof |
06/11/2014 | CN102600177B External medicament for treating skin diseases and application thereof |
06/11/2014 | CN102596936B Antiviral compounds |
06/11/2014 | CN102596251B High strength seamless alginate capsules |
06/11/2014 | CN102579365B Risperidone microsphere preparation and preparation method thereof |
06/11/2014 | CN102559828B Method for preparing astragaloside IV by converting total saponins of astragalus by microorganisms |
06/11/2014 | CN102557983B (4-substituted benzoyl) fluorobenzene salicylamide compound and application thereof |
06/11/2014 | CN102552234B Meclofenoxate hydrochloride medicinal composition and method for preparing freeze-drying powder injection of meclofenoxate hydrochloride medicinal composition |
06/11/2014 | CN102531933B Natural product Bostrycin derivates II and preparation method and application thereof |
06/11/2014 | CN102525880B Aprepitant solid dispersion composition |
06/11/2014 | CN102497856B Ketorolac tromethamine compositions for treating or preventing ocular pain |
06/11/2014 | CN102477065B Novel 16, 17-ketal intermediate for preparing budesonide |
06/11/2014 | CN102477064B Novel 16,17-ketal intermediate for preparing ciclesonide |
06/11/2014 | CN102477058B New 16,17-dihydroxy intermediate for preparing budesonide |
06/11/2014 | CN102443613B Antrodia camphorata anti-cancer active substance and preparation method and application thereof |
06/11/2014 | CN102442964B N1, N4-di-n-butyl-3, 6-dimethyl-1, 2, 4, 5-tetrazine-1, 4-dicarboximide as well as preparation method and application thereof |
06/11/2014 | CN102423319B Traditional Chinese medicine composition for treating oral ulcer |
06/11/2014 | CN102405217B Azaazulene compounds |
06/11/2014 | CN102333781B Tricyclic pyrazolopyrimidine derivative |
06/11/2014 | CN102333762B Ethanamine compounds and application for treating depression |
06/11/2014 | CN102321134B Compound, preparation method and application |
06/11/2014 | CN102293766B Application of active natural product B used for preparing antifungal product |
06/11/2014 | CN102267989B 2-methyl-benzofuran compounds and preparation and application thereof |
06/11/2014 | CN102256973B Corydaline derivatives useful for reducing lipid levels |
06/11/2014 | CN102256963B Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
06/11/2014 | CN102250171B Rutin ester compound and application thereof in medicaments |
06/11/2014 | CN102239171B Kinase inhibitors with improved cyp safety profile |
06/11/2014 | CN102232938B Metaxalone capsule and preparation method thereof |
06/11/2014 | CN102227416B Method for producing phenolphthalein using heteropolyacid catalyst |
06/11/2014 | CN102218065B New application of aloperin in pharmacy |
06/11/2014 | CN102188385B Sustained-release pellets containing nebivolol as active component and preparation method thereof |
06/11/2014 | CN102151252B Glipizide osmotic pump type controlled release tablet |
06/11/2014 | CN102140100B Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof |
06/11/2014 | CN102124006B Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
06/11/2014 | CN102066356B Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
06/11/2014 | CN102060722B Arsenic compound and preparation method and use thereof |
06/11/2014 | CN102058888B Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof |
06/11/2014 | CN102057050B Method for producing sphingolipids by enzymatic N-acylation of lysosphingolipids using a lipase and a fatty acid glycerol ester |
06/11/2014 | CN102038691B Composite preparation of vitamins and amino acids and preparation method thereof |
06/11/2014 | CN102019031B Health preserving pad |
06/11/2014 | CN101952241B Method of treating vitamin B12 deficiency |
06/11/2014 | CN101945656B Novel use of 3,3'-diindolylmethane |
06/11/2014 | CN101939303B Novel crystalline forms |
06/11/2014 | CN101932573B Novel pyridinones and pyridazinones |
06/11/2014 | CN101925356B Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation |
06/11/2014 | CN101838202B Total terpenoids of ferula dissecta as well as medical application and preparation method thereof |
06/11/2014 | CN101804048B Antiparasitic composition for animal |
06/11/2014 | CN101784550B Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
06/11/2014 | CN101742994B Telomerase activating compounds and methods of use thereof |
06/11/2014 | CN101657191B Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
06/11/2014 | CN101595100B Heterocyclic-substituted piperidine as orl-1 ligands |
06/11/2014 | CN101568344B Pdt treatment method for cellulites and cosmetic use |
06/11/2014 | CN101507728B Composite for preventing and treating body acidification of diabetic |
06/11/2014 | CN101264307B Common ginger root compound peptide composition and preparation thereof |
06/10/2014 | US8748661 Polyamino polyketide antibiotics and uses thereof |
06/10/2014 | US8748649 Di-fluoro containing compounds as cysteine protease inhibitors |
06/10/2014 | US8748632 Positive allosteric modulators of group II mGluRs |
06/10/2014 | US8748627 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
06/10/2014 | US8748626 Oxazole and thiazole compounds as KSP inhibitors |
06/10/2014 | US8748624 Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists |
06/10/2014 | US8748623 Pyridinecarboxamides as CXCR2 modulators |
06/10/2014 | US8748622 Process for the preparation of 4-{4[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate |
06/10/2014 | US8748621 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
06/10/2014 | US8748620 Thyroid hormone β receptor agonist |
06/10/2014 | US8748614 Substituted isoquinoline and isoquinolinone derivatives |
06/10/2014 | US8748613 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
06/10/2014 | US8748612 Modulators of cystic fibrosis transmembrane conductance regulator |
06/10/2014 | US8748603 Crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]THIO]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide |
06/10/2014 | US8748600 Cyclic triazo sodium channel blockers |
06/10/2014 | US8748599 Cyclic triazo sodium channel blockers |
06/10/2014 | US8748597 2,4-pyrimidinediamine compounds and their uses |
06/10/2014 | US8748595 Methods for fucoidan purification from sea weed extracts |
06/10/2014 | US8748497 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
06/10/2014 | US8748496 Methods of treatment of hyperuricemia and associated disease states |
06/10/2014 | US8748495 Method of preparing oil suspensions of carotenoid with low viscosity and high fluidity and use thereof |
06/10/2014 | US8748494 Method for improving the therapeutic efficacy of curcuminoids and their analogs |
06/10/2014 | US8748493 Inhibitors of cathepsin S for prevention or treatment of obesity-associated disorders |
06/10/2014 | US8748491 Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivatives and their uses |
06/10/2014 | US8748488 Methods and compositions for administration of oxybutynin |
06/10/2014 | US8748486 Inhibitors of yeast filamentous growth and method of their manufacture |
06/10/2014 | US8748485 Compound and medical use thereof |
06/10/2014 | US8748484 Organometallic anti-cancer complexes |
06/10/2014 | US8748483 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome |
06/10/2014 | US8748482 Lubiprostone crystal, the use and the method for the preparation thereof |
06/10/2014 | US8748481 Method for treating gastrointestinal disorder |
06/10/2014 | US8748480 Methods for treating opioid tolerance |
06/10/2014 | US8748479 Process for purifying crude furan 2,5-dicarboxylic acid using hydrogenation |
06/10/2014 | US8748478 Sulfamides as TRPM8 modulators |
06/10/2014 | US8748476 Darifenacin for use in the treatment of urgency induced by overactive bladder |
06/10/2014 | US8748475 Methods and compositions for treating lupus |
06/10/2014 | US8748473 Methods of treating post-traumatic stress disorder using pro-neurogenic compounds |
06/10/2014 | US8748472 Stabilized formulations of CNS compounds |
06/10/2014 | US8748471 2-alkyl-cycloalk(en)yl-carboxamides |
06/10/2014 | US8748470 Methods for treating ovarian cancer by inhibiting fatty acid binding proteins |
06/10/2014 | US8748469 IDO inhibitors |